Literature DB >> 7622937

The time of occurrence of liver metastasis in carcinoma of the pancreas.

K Amikura1, M Kobari, S Matsuno.   

Abstract

By measuring the doubling time of liver metastasis, the authors investigated the possibility of occult liver metastasis at the time of pancreatectomy in patients with pancreatic carcinoma. We calculated tumor doubling times of liver metastases in six patients after pancreatectomy for periampullary carcinoma and compared with cell doubling times. We also calculated the diameters of the occult liver metastases at the time of pancreatectomy on the assumption that the growth rates of liver metastasis were constant. Tumor doubling times of liver metastases in six patients were 34, 32, 318, 108, 78, and 27 d, respectively. In two of these patients, tumor doubling times, compared with cell doubling times of 51 and 52 h for PK-36 and PK-59 established from the same patients with carcinoma of the pancreas, were about 15 times as long as those of cultured cell lines. The calculated sizes of the occult liver metastases at the time of pancreatectomy in these six patients were 2.4, 0.14, 19.0, 8.2, 3.5, and 4.2 mm. In five of these six patients, the calculated sizes were in the range between 10 microns and 1 cm. These results indicated occult liver metastases had already existed in patients with carcinoma of the pancreas at the time of pancreatectomy and were too small to be detected by imaging technique. We cannot improve survival rates in carcinoma of the pancreas by surgical management alone. For further improvement in survival rate of patients with carcinoma of the pancreas to occur, effective adjuvant therapies to prevent liver metastases must complement surgical management.

Entities:  

Mesh:

Year:  1995        PMID: 7622937     DOI: 10.1007/BF02788531

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model.

Authors:  F M Marincola; L F Da Pozzo; B J Drucker; W D Holder
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  Time of occurrence of pulmonary metastasis from carcinoma of colon and rectum.

Authors:  V P COLLINS
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

3.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

4.  Growth rate of hepatic metastases in colorectal carcinoma.

Authors:  I G Finlay; D Meek; F Brunton; C S McArdle
Journal:  Br J Surg       Date:  1988-07       Impact factor: 6.939

5.  The cross rates of growth of human mammary carcinoma.

Authors:  S Kusama; J S Spratt; W L Donegan; F R Watson; C Cunningham
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

6.  Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.

Authors:  K E Bakkevold; B Kambestad
Journal:  Eur J Surg Oncol       Date:  1993-04       Impact factor: 4.424

7.  Carcinoma of the ampulla of Vater.

Authors:  Y L Matory; J Gaynor; M Brennan
Journal:  Surg Gynecol Obstet       Date:  1993-10

8.  The importance of tumour volume in the prognosis of radically treated periampullary carcinomas.

Authors:  F Sellner; E Machacek
Journal:  Eur J Surg       Date:  1993-02

9.  Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs.

Authors:  M Kobari; H Hisano; S Matsuno; T Sato; M Kan; T Tachibana
Journal:  Tohoku J Exp Med       Date:  1986-11       Impact factor: 1.848

Review 10.  The current status of the Whipple operation for periampullary carcinoma.

Authors:  D W Crist; J L Cameron
Journal:  Adv Surg       Date:  1992
View more
  33 in total

Review 1.  Adjuvant therapy in pancreatic cancer.

Authors:  P Ghaneh; J Slavin; R Sutton; M Hartley; J P Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

3.  Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

Authors:  C Iacono; L Bortolasi; E Facci; G Falezza; G Prati; G Mangiante; G Serio
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 4.  Results of adjuvant therapy in resected pancreatic cancer.

Authors:  A Andrén-Sandberg; P L Bäckman; R Andersson
Journal:  Int J Pancreatol       Date:  1997-02

5.  Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.

Authors:  Hiroshi Haeno; Mithat Gonen; Meghan B Davis; Joseph M Herman; Christine A Iacobuzio-Donahue; Franziska Michor
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 6.  Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

Authors:  H G Smeenk; T C K Tran; J Erdmann; C H J van Eijck; J Jeekel
Journal:  Langenbecks Arch Surg       Date:  2004-05-14       Impact factor: 3.445

7.  Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.

Authors:  Maik Kilian; Jan Ilga Gregor; Ina Heukamp; Chris Braumann; Hans Guski; Ingolf Schimke; Martin Karl Walz; Christoph Andreas Jacobi; Frank Axel Wenger
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

Review 8.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

9.  Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Authors:  Pavlos Papavasiliou; John P Hoffman; Steven J Cohen; Joshua E Meyer; James C Watson; Yun Shin Chun
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

Review 10.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.